VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

SOHO 2022 | Why should autologous transplant remain the SOC in myeloma?

Amrita Krishnan, MD, City of Hope, Duarte, CA, briefly explains the benefits of autologous transplantation in multiple myeloma, and why this should remain the standard of care (SOC) in the field. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter